Ryan W. Huey, M.D.
Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2012 | University of Oklahoma College of Medicine, Oklahoma City, OK, USA, MD, Medicine |
| 2008 | Texas Christian University, Fort Worth, TX, USA, BA, Biology |
Postgraduate Training
| 2016-2019 | Clinical Fellowship, Hematology and Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2012-2015 | Clinical Residency, Internal Medicine, Duke University Medical Center, Durham, NC |
Experience & Service
Academic Appointments
Instructor, Duke University Medical Center, Durham, NC, 2015 - 2016
Administrative Appointments/Responsibilities
Scholar, Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019
Honors & Awards
| 2019 | Conquer Cancer Foundation of ASCO Merit Award |
| 2018 | LBJ Hospital 2nd Year Fellow of the Year Award, The University of Texas MD Anderson Cancer Center |
| 2018 | NCCN Fellows Recognition Program |
| 2012 | F. Daniel Duffy, M.D. Internal Medicine Award, University of Oklahoma College of Medicine |
| 2011 | Podalirian Award, University of Oklahoma College of Medicine |
| 2011 | Gold Humanism Honor Society |
| 2008 | Phi Beta Kappa, Texas Christian University |
| 2008 | Jean J. and William Tucker Award for Leadership and Service, Texas Christian University |
| 2008 | Janet Perry Award for Overcoming Adversity, Texas Christian University |
Selected Publications
Peer-Reviewed Articles
- Huey RW, George GC, Phillips P, White R, Fu S, Janku F, Karp DD, Naing A, Piha-Paul S, Subbiah V, Tsimberidou AM, Pant S, Yap TA, Rodon J, Meric-Bernstam F, Shih YT, Hong DS. Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials. Oncologist. e-Pub 2021. PMID: 33783054.
- Huey RW, Makawita S, Xiao L, Matamoros A, Estrella JS, Overman MJ, Varadhachary GR, Raghav K. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait. BMC Cancer 19(1):965, 2019. e-Pub 2019. PMID: 31623602.
- Selig BP, Furr JR, Huey RW, Moran C, Alluri VN, Medders GR, Mumm CD, Hallford HG, Mulvihill JJ. Cancer chemotherapeutic agents as human teratogens. Birth Defects Res A Clin Mol Teratol 94(8):626-50, 2012. e-Pub 2012. PMID: 22851372.
- Teague TK, Tan C, Marino JH, Davis BK, Taylor AA, Huey RW, Van De Wiele CJ. CD28 expression redefines thymocyte development during the pre-T to DP transition. Int Immunol 22(5):387-97, 2010. e-Pub 2010. PMID: 20203098.
Editorials
- Huey RW, Hawk E, Offodile AC. Mind the Gap: Precision Oncology and Its Potential to Widen Disparities. J Oncol Pract 15(6):301-304, 2019. PMID: 31112478.
Grant & Contract Support
| Title: | A Multicenter, Open-label, Phase 1a/b Study of HC-7366 in Subjects With Advanced Solid Tumors |
| Funding Source: | HiberCell, Inc |
| Role: | Co-Investigator |
| Title: | STRATEGIC ALLIANCE: 2020-0902-A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Sintilimab for Advanced Rare Cancers (SiARa Cancer Study) – Cancer of Unknown Primary (SiARa-CUP) |
| Funding Source: | Innovent Biologics |
| Role: | Collaborator |